nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PPARG—thyroid cancer	0.253	0.703	CbGaD
Indomethacin—PTGS2—thyroid cancer	0.107	0.297	CbGaD
Indomethacin—AKR1C3—Doxorubicin—thyroid cancer	0.0674	0.155	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—thyroid cancer	0.0506	0.117	CbGbCtD
Indomethacin—ABCC1—Vandetanib—thyroid cancer	0.0408	0.0941	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—thyroid cancer	0.0396	0.0911	CbGbCtD
Indomethacin—UGT1A9—Sorafenib—thyroid cancer	0.0366	0.0843	CbGbCtD
Indomethacin—ABCC4—Sorafenib—thyroid cancer	0.0306	0.0705	CbGbCtD
Indomethacin—UGT1A1—Sorafenib—thyroid cancer	0.03	0.069	CbGbCtD
Indomethacin—ABCC1—Epirubicin—thyroid cancer	0.0281	0.0647	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—thyroid cancer	0.0243	0.056	CbGbCtD
Indomethacin—ALB—Vandetanib—thyroid cancer	0.0188	0.0434	CbGbCtD
Indomethacin—ABCC2—Sorafenib—thyroid cancer	0.0182	0.042	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—thyroid cancer	0.0149	0.0344	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—thyroid cancer	0.0111	0.0255	CbGbCtD
Indomethacin—CYP2C19—Sorafenib—thyroid cancer	0.00736	0.017	CbGbCtD
Indomethacin—CYP2C9—Sorafenib—thyroid cancer	0.00612	0.0141	CbGbCtD
Indomethacin—ABCB1—Sorafenib—thyroid cancer	0.00594	0.0137	CbGbCtD
Indomethacin—CES1—larynx—thyroid cancer	0.00445	0.114	CbGeAlD
Indomethacin—ABCB1—Doxorubicin—thyroid cancer	0.0036	0.0083	CbGbCtD
Indomethacin—PTGR2—saliva-secreting gland—thyroid cancer	0.00231	0.0593	CbGeAlD
Indomethacin—PPARA—neck—thyroid cancer	0.00159	0.0408	CbGeAlD
Indomethacin—GLO1—saliva-secreting gland—thyroid cancer	0.00143	0.0366	CbGeAlD
Indomethacin—PTGR2—thyroid gland—thyroid cancer	0.00141	0.0362	CbGeAlD
Indomethacin—PLA2G2A—saliva-secreting gland—thyroid cancer	0.00133	0.0341	CbGeAlD
Indomethacin—PTGR2—head—thyroid cancer	0.00125	0.0321	CbGeAlD
Indomethacin—CES1—neck—thyroid cancer	0.00118	0.0303	CbGeAlD
Indomethacin—GLO1—trachea—thyroid cancer	0.0011	0.0283	CbGeAlD
Indomethacin—PLA2G2A—trachea—thyroid cancer	0.00102	0.0263	CbGeAlD
Indomethacin—CXCL8—trachea—thyroid cancer	0.00101	0.026	CbGeAlD
Indomethacin—PTGR2—lymph node—thyroid cancer	0.000877	0.0225	CbGeAlD
Indomethacin—PPARG—neck—thyroid cancer	0.000875	0.0224	CbGeAlD
Indomethacin—GLO1—thyroid gland—thyroid cancer	0.000872	0.0224	CbGeAlD
Indomethacin—Bezafibrate—PPARG—thyroid cancer	0.000837	0.375	CrCbGaD
Indomethacin—PLA2G2A—thyroid gland—thyroid cancer	0.000811	0.0208	CbGeAlD
Indomethacin—ABCC6—thyroid gland—thyroid cancer	0.000802	0.0206	CbGeAlD
Indomethacin—AKR1C3—trachea—thyroid cancer	0.000795	0.0204	CbGeAlD
Indomethacin—GLO1—head—thyroid cancer	0.000774	0.0198	CbGeAlD
Indomethacin—PPARA—thyroid gland—thyroid cancer	0.000757	0.0194	CbGeAlD
Indomethacin—PLA2G2A—head—thyroid cancer	0.000719	0.0184	CbGeAlD
Indomethacin—ABCC6—head—thyroid cancer	0.000712	0.0183	CbGeAlD
Indomethacin—PPARA—head—thyroid cancer	0.000672	0.0172	CbGeAlD
Indomethacin—SLC10A1—head—thyroid cancer	0.000646	0.0166	CbGeAlD
Indomethacin—Bromfenac—PTGS2—thyroid cancer	0.000639	0.287	CrCbGaD
Indomethacin—AKR1C3—thyroid gland—thyroid cancer	0.000629	0.0161	CbGeAlD
Indomethacin—CES1—thyroid gland—thyroid cancer	0.000562	0.0144	CbGeAlD
Indomethacin—GLO1—lymph node—thyroid cancer	0.000542	0.0139	CbGeAlD
Indomethacin—PLA2G2A—lymph node—thyroid cancer	0.000504	0.0129	CbGeAlD
Indomethacin—CXCL8—lymph node—thyroid cancer	0.000499	0.0128	CbGeAlD
Indomethacin—CES1—head—thyroid cancer	0.000499	0.0128	CbGeAlD
Indomethacin—PPARA—lymph node—thyroid cancer	0.00047	0.0121	CbGeAlD
Indomethacin—ABCC3—thyroid gland—thyroid cancer	0.000458	0.0117	CbGeAlD
Indomethacin—Tolmetin—PTGS2—thyroid cancer	0.000429	0.193	CrCbGaD
Indomethacin—PPARG—thyroid gland—thyroid cancer	0.000416	0.0107	CbGeAlD
Indomethacin—ABCC1—trachea—thyroid cancer	0.000408	0.0104	CbGeAlD
Indomethacin—ABCC3—head—thyroid cancer	0.000406	0.0104	CbGeAlD
Indomethacin—AKR1C3—lymph node—thyroid cancer	0.000391	0.01	CbGeAlD
Indomethacin—ABCC4—thyroid gland—thyroid cancer	0.000378	0.00969	CbGeAlD
Indomethacin—PPARG—head—thyroid cancer	0.000369	0.00947	CbGeAlD
Indomethacin—CES1—lymph node—thyroid cancer	0.000349	0.00895	CbGeAlD
Indomethacin—SLCO1A2—head—thyroid cancer	0.000349	0.00894	CbGeAlD
Indomethacin—ABCC4—head—thyroid cancer	0.000335	0.0086	CbGeAlD
Indomethacin—SLC22A8—head—thyroid cancer	0.000333	0.00853	CbGeAlD
Indomethacin—Naproxen—PTGS2—thyroid cancer	0.000323	0.145	CrCbGaD
Indomethacin—ABCC1—thyroid gland—thyroid cancer	0.000322	0.00827	CbGeAlD
Indomethacin—ABCC3—lymph node—thyroid cancer	0.000285	0.0073	CbGeAlD
Indomethacin—PTGS1—trachea—thyroid cancer	0.000281	0.00721	CbGeAlD
Indomethacin—PTGS2—trachea—thyroid cancer	0.000269	0.0069	CbGeAlD
Indomethacin—PPARG—lymph node—thyroid cancer	0.000259	0.00663	CbGeAlD
Indomethacin—ALB—lymph node—thyroid cancer	0.000243	0.00622	CbGeAlD
Indomethacin—ABCC4—lymph node—thyroid cancer	0.000235	0.00602	CbGeAlD
Indomethacin—ABCC2—lymph node—thyroid cancer	0.000227	0.00583	CbGeAlD
Indomethacin—Syncope—Sorafenib—thyroid cancer	0.000226	0.00251	CcSEcCtD
Indomethacin—Leukopenia—Sorafenib—thyroid cancer	0.000226	0.00251	CcSEcCtD
Indomethacin—Dysarthria—Epirubicin—thyroid cancer	0.000225	0.0025	CcSEcCtD
Indomethacin—Ulcer—Epirubicin—thyroid cancer	0.000225	0.0025	CcSEcCtD
Indomethacin—PTGS1—thyroid gland—thyroid cancer	0.000223	0.00571	CbGeAlD
Indomethacin—Loss of consciousness—Sorafenib—thyroid cancer	0.000222	0.00246	CcSEcCtD
Indomethacin—Asthenia—Vandetanib—thyroid cancer	0.000219	0.00243	CcSEcCtD
Indomethacin—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.000218	0.00243	CcSEcCtD
Indomethacin—Hypertension—Sorafenib—thyroid cancer	0.000218	0.00242	CcSEcCtD
Indomethacin—Pruritus—Vandetanib—thyroid cancer	0.000216	0.0024	CcSEcCtD
Indomethacin—Oliguria—Doxorubicin—thyroid cancer	0.000214	0.00238	CcSEcCtD
Indomethacin—Dyskinesia—Doxorubicin—thyroid cancer	0.00021	0.00233	CcSEcCtD
Indomethacin—Hyperkalaemia—Epirubicin—thyroid cancer	0.000209	0.00233	CcSEcCtD
Indomethacin—Diarrhoea—Vandetanib—thyroid cancer	0.000209	0.00232	CcSEcCtD
Indomethacin—Dysarthria—Doxorubicin—thyroid cancer	0.000208	0.00232	CcSEcCtD
Indomethacin—Ulcer—Doxorubicin—thyroid cancer	0.000208	0.00232	CcSEcCtD
Indomethacin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000206	0.00229	CcSEcCtD
Indomethacin—Colitis—Epirubicin—thyroid cancer	0.000205	0.00227	CcSEcCtD
Indomethacin—Skin exfoliation—Epirubicin—thyroid cancer	0.000203	0.00226	CcSEcCtD
Indomethacin—Shock—Sorafenib—thyroid cancer	0.000202	0.00225	CcSEcCtD
Indomethacin—Fluid retention—Epirubicin—thyroid cancer	0.000202	0.00225	CcSEcCtD
Indomethacin—Dizziness—Vandetanib—thyroid cancer	0.000202	0.00224	CcSEcCtD
Indomethacin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000201	0.00224	CcSEcCtD
Indomethacin—ABCC1—lymph node—thyroid cancer	0.0002	0.00514	CbGeAlD
Indomethacin—Aplastic anaemia—Epirubicin—thyroid cancer	0.0002	0.00222	CcSEcCtD
Indomethacin—PTGS1—head—thyroid cancer	0.000197	0.00506	CbGeAlD
Indomethacin—Anorexia—Sorafenib—thyroid cancer	0.000196	0.00218	CcSEcCtD
Indomethacin—Coma—Epirubicin—thyroid cancer	0.000195	0.00216	CcSEcCtD
Indomethacin—Vomiting—Vandetanib—thyroid cancer	0.000194	0.00216	CcSEcCtD
Indomethacin—Hyperkalaemia—Doxorubicin—thyroid cancer	0.000194	0.00215	CcSEcCtD
Indomethacin—Mouth ulceration—Epirubicin—thyroid cancer	0.000193	0.00214	CcSEcCtD
Indomethacin—Ecchymosis—Epirubicin—thyroid cancer	0.000193	0.00214	CcSEcCtD
Indomethacin—Rash—Vandetanib—thyroid cancer	0.000192	0.00214	CcSEcCtD
Indomethacin—Dermatitis—Vandetanib—thyroid cancer	0.000192	0.00214	CcSEcCtD
Indomethacin—Headache—Vandetanib—thyroid cancer	0.000191	0.00212	CcSEcCtD
Indomethacin—Pulmonary oedema—Epirubicin—thyroid cancer	0.00019	0.00211	CcSEcCtD
Indomethacin—Colitis—Doxorubicin—thyroid cancer	0.000189	0.0021	CcSEcCtD
Indomethacin—PTGS2—head—thyroid cancer	0.000189	0.00484	CbGeAlD
Indomethacin—Skin exfoliation—Doxorubicin—thyroid cancer	0.000188	0.00209	CcSEcCtD
Indomethacin—Fluid retention—Doxorubicin—thyroid cancer	0.000187	0.00208	CcSEcCtD
Indomethacin—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000185	0.00206	CcSEcCtD
Indomethacin—Dyspnoea—Sorafenib—thyroid cancer	0.000183	0.00204	CcSEcCtD
Indomethacin—Nausea—Vandetanib—thyroid cancer	0.000181	0.00201	CcSEcCtD
Indomethacin—Dyspepsia—Sorafenib—thyroid cancer	0.000181	0.00201	CcSEcCtD
Indomethacin—Coma—Doxorubicin—thyroid cancer	0.00018	0.002	CcSEcCtD
Indomethacin—Decreased appetite—Sorafenib—thyroid cancer	0.000179	0.00199	CcSEcCtD
Indomethacin—Thrombophlebitis—Epirubicin—thyroid cancer	0.000179	0.00199	CcSEcCtD
Indomethacin—Ecchymosis—Doxorubicin—thyroid cancer	0.000178	0.00198	CcSEcCtD
Indomethacin—Mouth ulceration—Doxorubicin—thyroid cancer	0.000178	0.00198	CcSEcCtD
Indomethacin—Fatigue—Sorafenib—thyroid cancer	0.000177	0.00197	CcSEcCtD
Indomethacin—Pain—Sorafenib—thyroid cancer	0.000176	0.00196	CcSEcCtD
Indomethacin—Constipation—Sorafenib—thyroid cancer	0.000176	0.00196	CcSEcCtD
Indomethacin—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000175	0.00195	CcSEcCtD
Indomethacin—Vascular purpura—Epirubicin—thyroid cancer	0.000173	0.00192	CcSEcCtD
Indomethacin—Eye pain—Epirubicin—thyroid cancer	0.000171	0.00191	CcSEcCtD
Indomethacin—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000171	0.0019	CcSEcCtD
Indomethacin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000168	0.00187	CcSEcCtD
Indomethacin—ABCB1—trachea—thyroid cancer	0.000166	0.00427	CbGeAlD
Indomethacin—Hot flush—Epirubicin—thyroid cancer	0.000165	0.00184	CcSEcCtD
Indomethacin—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000165	0.00184	CcSEcCtD
Indomethacin—Menopausal symptoms—Epirubicin—thyroid cancer	0.000164	0.00182	CcSEcCtD
Indomethacin—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000164	0.00182	CcSEcCtD
Indomethacin—Urticaria—Sorafenib—thyroid cancer	0.000163	0.00182	CcSEcCtD
Indomethacin—Body temperature increased—Sorafenib—thyroid cancer	0.000163	0.00181	CcSEcCtD
Indomethacin—Abdominal pain—Sorafenib—thyroid cancer	0.000163	0.00181	CcSEcCtD
Indomethacin—Renal impairment—Epirubicin—thyroid cancer	0.000163	0.00181	CcSEcCtD
Indomethacin—Purpura—Epirubicin—thyroid cancer	0.00016	0.00178	CcSEcCtD
Indomethacin—Vascular purpura—Doxorubicin—thyroid cancer	0.00016	0.00178	CcSEcCtD
Indomethacin—Eye pain—Doxorubicin—thyroid cancer	0.000159	0.00176	CcSEcCtD
Indomethacin—Hypoglycaemia—Epirubicin—thyroid cancer	0.000158	0.00176	CcSEcCtD
Indomethacin—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000158	0.00175	CcSEcCtD
Indomethacin—Hyponatraemia—Epirubicin—thyroid cancer	0.000155	0.00173	CcSEcCtD
Indomethacin—Osteoarthritis—Epirubicin—thyroid cancer	0.000155	0.00172	CcSEcCtD
Indomethacin—Diplopia—Epirubicin—thyroid cancer	0.000155	0.00172	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000155	0.00172	CcSEcCtD
Indomethacin—Hot flush—Doxorubicin—thyroid cancer	0.000153	0.0017	CcSEcCtD
Indomethacin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000152	0.00169	CcSEcCtD
Indomethacin—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000152	0.00169	CcSEcCtD
Indomethacin—Hypersensitivity—Sorafenib—thyroid cancer	0.000152	0.00169	CcSEcCtD
Indomethacin—Renal impairment—Doxorubicin—thyroid cancer	0.00015	0.00167	CcSEcCtD
Indomethacin—Purpura—Doxorubicin—thyroid cancer	0.000148	0.00165	CcSEcCtD
Indomethacin—Asthenia—Sorafenib—thyroid cancer	0.000148	0.00164	CcSEcCtD
Indomethacin—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000147	0.00163	CcSEcCtD
Indomethacin—Pruritus—Sorafenib—thyroid cancer	0.000146	0.00162	CcSEcCtD
Indomethacin—Hyponatraemia—Doxorubicin—thyroid cancer	0.000144	0.0016	CcSEcCtD
Indomethacin—Diplopia—Doxorubicin—thyroid cancer	0.000143	0.00159	CcSEcCtD
Indomethacin—Osteoarthritis—Doxorubicin—thyroid cancer	0.000143	0.00159	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000143	0.00159	CcSEcCtD
Indomethacin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000141	0.00157	CcSEcCtD
Indomethacin—Diarrhoea—Sorafenib—thyroid cancer	0.000141	0.00156	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000139	0.00155	CcSEcCtD
Indomethacin—PTGS1—lymph node—thyroid cancer	0.000138	0.00355	CbGeAlD
Indomethacin—Gastritis—Epirubicin—thyroid cancer	0.000137	0.00152	CcSEcCtD
Indomethacin—Muscular weakness—Epirubicin—thyroid cancer	0.000136	0.00152	CcSEcCtD
Indomethacin—Dizziness—Sorafenib—thyroid cancer	0.000136	0.00151	CcSEcCtD
Indomethacin—Abdominal distension—Epirubicin—thyroid cancer	0.000135	0.0015	CcSEcCtD
Indomethacin—Asthma—Epirubicin—thyroid cancer	0.000134	0.00149	CcSEcCtD
Indomethacin—PTGS2—lymph node—thyroid cancer	0.000132	0.00339	CbGeAlD
Indomethacin—ABCB1—thyroid gland—thyroid cancer	0.000132	0.00337	CbGeAlD
Indomethacin—Vomiting—Sorafenib—thyroid cancer	0.000131	0.00145	CcSEcCtD
Indomethacin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000131	0.00145	CcSEcCtD
Indomethacin—Rash—Sorafenib—thyroid cancer	0.00013	0.00144	CcSEcCtD
Indomethacin—Dermatitis—Sorafenib—thyroid cancer	0.00013	0.00144	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000129	0.00143	CcSEcCtD
Indomethacin—Headache—Sorafenib—thyroid cancer	0.000129	0.00143	CcSEcCtD
Indomethacin—Pancytopenia—Epirubicin—thyroid cancer	0.000127	0.00141	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—thyroid cancer	0.000127	0.00141	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—thyroid cancer	0.000126	0.0014	CcSEcCtD
Indomethacin—Abdominal distension—Doxorubicin—thyroid cancer	0.000125	0.00138	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—thyroid cancer	0.000124	0.00138	CcSEcCtD
Indomethacin—Pollakiuria—Epirubicin—thyroid cancer	0.000123	0.00137	CcSEcCtD
Indomethacin—Nausea—Sorafenib—thyroid cancer	0.000122	0.00136	CcSEcCtD
Indomethacin—Weight increased—Epirubicin—thyroid cancer	0.000122	0.00135	CcSEcCtD
Indomethacin—Hyperglycaemia—Epirubicin—thyroid cancer	0.000121	0.00134	CcSEcCtD
Indomethacin—Drowsiness—Epirubicin—thyroid cancer	0.000119	0.00133	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000118	0.00131	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—thyroid cancer	0.000117	0.00131	CcSEcCtD
Indomethacin—Renal failure—Epirubicin—thyroid cancer	0.000117	0.0013	CcSEcCtD
Indomethacin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000117	0.0013	CcSEcCtD
Indomethacin—ABCB1—head—thyroid cancer	0.000117	0.00299	CbGeAlD
Indomethacin—Stomatitis—Epirubicin—thyroid cancer	0.000116	0.00129	CcSEcCtD
Indomethacin—Jaundice—Epirubicin—thyroid cancer	0.000116	0.00129	CcSEcCtD
Indomethacin—Sweating—Epirubicin—thyroid cancer	0.000114	0.00127	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—thyroid cancer	0.000114	0.00127	CcSEcCtD
Indomethacin—Haematuria—Epirubicin—thyroid cancer	0.000114	0.00126	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—thyroid cancer	0.000113	0.00125	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—thyroid cancer	0.000112	0.00125	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000112	0.00124	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—thyroid cancer	0.000111	0.00124	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—thyroid cancer	0.00011	0.00123	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000109	0.00122	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—thyroid cancer	0.000109	0.00121	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—thyroid cancer	0.000108	0.00121	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000108	0.0012	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—thyroid cancer	0.000108	0.0012	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—thyroid cancer	0.000107	0.0012	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—thyroid cancer	0.000107	0.0012	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—thyroid cancer	0.000107	0.00119	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—thyroid cancer	0.000107	0.00119	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—thyroid cancer	0.000106	0.00118	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—thyroid cancer	0.000105	0.00117	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—thyroid cancer	0.000104	0.00116	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—thyroid cancer	0.000103	0.00114	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—thyroid cancer	0.000101	0.00112	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—thyroid cancer	0.000101	0.00112	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—thyroid cancer	9.98e-05	0.00111	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—thyroid cancer	9.95e-05	0.00111	CcSEcCtD
Indomethacin—Flushing—Epirubicin—thyroid cancer	9.93e-05	0.0011	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—thyroid cancer	9.9e-05	0.0011	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—thyroid cancer	9.9e-05	0.0011	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—thyroid cancer	9.56e-05	0.00106	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—thyroid cancer	9.46e-05	0.00105	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—thyroid cancer	9.36e-05	0.00104	CcSEcCtD
Indomethacin—Erythema—Epirubicin—thyroid cancer	9.31e-05	0.00104	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—thyroid cancer	9.23e-05	0.00103	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—thyroid cancer	9.19e-05	0.00102	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—thyroid cancer	9.18e-05	0.00102	CcSEcCtD
Indomethacin—Tension—Epirubicin—thyroid cancer	9.14e-05	0.00102	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—thyroid cancer	9.05e-05	0.00101	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—thyroid cancer	8.84e-05	0.000983	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—thyroid cancer	8.78e-05	0.000976	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—thyroid cancer	8.75e-05	0.000973	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—thyroid cancer	8.64e-05	0.000961	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—thyroid cancer	8.62e-05	0.000958	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—thyroid cancer	8.61e-05	0.000957	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—thyroid cancer	8.49e-05	0.000944	CcSEcCtD
Indomethacin—Tension—Doxorubicin—thyroid cancer	8.46e-05	0.00094	CcSEcCtD
Indomethacin—Malaise—Epirubicin—thyroid cancer	8.4e-05	0.000934	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—thyroid cancer	8.37e-05	0.000931	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—thyroid cancer	8.37e-05	0.000931	CcSEcCtD
Indomethacin—Syncope—Epirubicin—thyroid cancer	8.35e-05	0.000929	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—thyroid cancer	8.34e-05	0.000927	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—thyroid cancer	8.23e-05	0.000915	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—thyroid cancer	8.19e-05	0.00091	CcSEcCtD
Indomethacin—ABCB1—lymph node—thyroid cancer	8.18e-05	0.0021	CbGeAlD
Indomethacin—Vision blurred—Doxorubicin—thyroid cancer	8.12e-05	0.000903	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—thyroid cancer	8.07e-05	0.000897	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—thyroid cancer	8.04e-05	0.000894	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—thyroid cancer	8e-05	0.000889	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—thyroid cancer	7.97e-05	0.000886	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—thyroid cancer	7.93e-05	0.000882	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—thyroid cancer	7.9e-05	0.000879	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—thyroid cancer	7.83e-05	0.000871	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—thyroid cancer	7.77e-05	0.000864	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—thyroid cancer	7.74e-05	0.000861	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—thyroid cancer	7.73e-05	0.000859	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—thyroid cancer	7.71e-05	0.000858	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—thyroid cancer	7.66e-05	0.000852	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—thyroid cancer	7.62e-05	0.000847	CcSEcCtD
Indomethacin—Oedema—Epirubicin—thyroid cancer	7.6e-05	0.000845	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—thyroid cancer	7.6e-05	0.000845	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—thyroid cancer	7.57e-05	0.000842	CcSEcCtD
Indomethacin—Shock—Epirubicin—thyroid cancer	7.48e-05	0.000832	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—thyroid cancer	7.47e-05	0.00083	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—thyroid cancer	7.44e-05	0.000828	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—thyroid cancer	7.44e-05	0.000827	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—thyroid cancer	7.42e-05	0.000825	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—thyroid cancer	7.35e-05	0.000817	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—thyroid cancer	7.34e-05	0.000816	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—thyroid cancer	7.31e-05	0.000813	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—thyroid cancer	7.25e-05	0.000806	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—thyroid cancer	7.25e-05	0.000806	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—thyroid cancer	7.1e-05	0.00079	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—thyroid cancer	7.09e-05	0.000789	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—thyroid cancer	7.03e-05	0.000782	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—thyroid cancer	7.03e-05	0.000782	CcSEcCtD
Indomethacin—Shock—Doxorubicin—thyroid cancer	6.92e-05	0.000769	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—thyroid cancer	6.89e-05	0.000766	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—thyroid cancer	6.88e-05	0.000765	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—thyroid cancer	6.86e-05	0.000763	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—thyroid cancer	6.83e-05	0.000759	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—thyroid cancer	6.8e-05	0.000756	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—thyroid cancer	6.78e-05	0.000754	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—thyroid cancer	6.76e-05	0.000751	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—thyroid cancer	6.7e-05	0.000746	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—thyroid cancer	6.69e-05	0.000744	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—thyroid cancer	6.61e-05	0.000735	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—thyroid cancer	6.57e-05	0.000731	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—thyroid cancer	6.55e-05	0.000729	CcSEcCtD
Indomethacin—Pain—Epirubicin—thyroid cancer	6.5e-05	0.000723	CcSEcCtD
Indomethacin—Constipation—Epirubicin—thyroid cancer	6.5e-05	0.000723	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—thyroid cancer	6.36e-05	0.000707	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—thyroid cancer	6.32e-05	0.000702	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—thyroid cancer	6.27e-05	0.000697	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—thyroid cancer	6.26e-05	0.000697	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—thyroid cancer	6.25e-05	0.000695	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—thyroid cancer	6.22e-05	0.000691	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—thyroid cancer	6.19e-05	0.000688	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—thyroid cancer	6.11e-05	0.00068	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—thyroid cancer	6.06e-05	0.000674	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—thyroid cancer	6.04e-05	0.000672	CcSEcCtD
Indomethacin—Pain—Doxorubicin—thyroid cancer	6.01e-05	0.000669	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—thyroid cancer	6.01e-05	0.000669	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—thyroid cancer	6.01e-05	0.000668	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—thyroid cancer	6.01e-05	0.000668	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—thyroid cancer	5.8e-05	0.000645	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—thyroid cancer	5.75e-05	0.00064	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—thyroid cancer	5.6e-05	0.000623	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—thyroid cancer	5.59e-05	0.000621	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—thyroid cancer	5.56e-05	0.000618	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—thyroid cancer	5.56e-05	0.000618	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—thyroid cancer	5.45e-05	0.000606	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—thyroid cancer	5.38e-05	0.000598	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—thyroid cancer	5.2e-05	0.000578	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—thyroid cancer	5.18e-05	0.000576	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—thyroid cancer	5.05e-05	0.000561	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—thyroid cancer	5.03e-05	0.000559	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—thyroid cancer	4.98e-05	0.000553	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—thyroid cancer	4.83e-05	0.000537	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—thyroid cancer	4.81e-05	0.000535	CcSEcCtD
Indomethacin—Rash—Epirubicin—thyroid cancer	4.79e-05	0.000533	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—thyroid cancer	4.79e-05	0.000532	CcSEcCtD
Indomethacin—Headache—Epirubicin—thyroid cancer	4.76e-05	0.00053	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—thyroid cancer	4.65e-05	0.000517	CcSEcCtD
Indomethacin—Nausea—Epirubicin—thyroid cancer	4.52e-05	0.000502	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—thyroid cancer	4.47e-05	0.000497	CcSEcCtD
Indomethacin—Rash—Doxorubicin—thyroid cancer	4.43e-05	0.000493	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—thyroid cancer	4.43e-05	0.000493	CcSEcCtD
Indomethacin—Headache—Doxorubicin—thyroid cancer	4.41e-05	0.00049	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—thyroid cancer	4.18e-05	0.000465	CcSEcCtD
Indomethacin—ALB—Metabolism—HPGD—thyroid cancer	1.48e-05	0.000197	CbGpPWpGaD
Indomethacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.47e-05	0.000196	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	1.46e-05	0.000195	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CCND1—thyroid cancer	1.45e-05	0.000193	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.45e-05	0.000193	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—SLC5A5—thyroid cancer	1.41e-05	0.000188	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.41e-05	0.000188	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—BRAF—thyroid cancer	1.4e-05	0.000187	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PPARG—thyroid cancer	1.4e-05	0.000187	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—PTEN—thyroid cancer	1.4e-05	0.000187	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.4e-05	0.000187	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CALCA—thyroid cancer	1.4e-05	0.000186	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.4e-05	0.000186	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—KRAS—thyroid cancer	1.39e-05	0.000185	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRG1—thyroid cancer	1.38e-05	0.000184	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—AKT1—thyroid cancer	1.37e-05	0.000182	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IFNA2—thyroid cancer	1.37e-05	0.000182	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDK1—thyroid cancer	1.36e-05	0.000181	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.36e-05	0.000181	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—PPARG—thyroid cancer	1.35e-05	0.000179	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HPGD—thyroid cancer	1.33e-05	0.000177	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.33e-05	0.000177	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.32e-05	0.000176	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—TPR—thyroid cancer	1.32e-05	0.000176	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	1.3e-05	0.000173	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PRKAR1A—thyroid cancer	1.3e-05	0.000173	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PTGS2—thyroid cancer	1.3e-05	0.000173	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HPGD—thyroid cancer	1.3e-05	0.000173	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDK1—thyroid cancer	1.27e-05	0.000169	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—RXRA—thyroid cancer	1.26e-05	0.000167	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—RXRA—thyroid cancer	1.26e-05	0.000167	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TPR—thyroid cancer	1.25e-05	0.000167	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NRAS—thyroid cancer	1.25e-05	0.000167	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.25e-05	0.000167	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TERT—thyroid cancer	1.24e-05	0.000165	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PRKAR1A—thyroid cancer	1.23e-05	0.000164	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.22e-05	0.000163	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.22e-05	0.000162	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—SLC5A5—thyroid cancer	1.21e-05	0.000162	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—SLC5A5—thyroid cancer	1.21e-05	0.000162	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HPGD—thyroid cancer	1.21e-05	0.000161	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PPARG—thyroid cancer	1.21e-05	0.000161	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.2e-05	0.00016	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.19e-05	0.000158	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—RXRA—thyroid cancer	1.19e-05	0.000158	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HIF1A—thyroid cancer	1.19e-05	0.000158	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.18e-05	0.000157	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.18e-05	0.000157	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MEN1—thyroid cancer	1.18e-05	0.000157	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—HRAS—thyroid cancer	1.18e-05	0.000157	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—SLC5A5—thyroid cancer	1.17e-05	0.000156	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.16e-05	0.000154	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—NRAS—thyroid cancer	1.15e-05	0.000154	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.14e-05	0.000152	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.14e-05	0.000152	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTGS2—thyroid cancer	1.13e-05	0.000151	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PTEN—thyroid cancer	1.13e-05	0.000151	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.13e-05	0.00015	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—NRAS—thyroid cancer	1.13e-05	0.00015	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	1.11e-05	0.000148	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTGS2—thyroid cancer	1.1e-05	0.000147	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.1e-05	0.000146	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—RXRA—thyroid cancer	1.09e-05	0.000146	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.09e-05	0.000145	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRG1—thyroid cancer	1.09e-05	0.000145	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.08e-05	0.000143	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—KRAS—thyroid cancer	1.08e-05	0.000143	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.06e-05	0.000142	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TPR—thyroid cancer	1.05e-05	0.00014	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.05e-05	0.00014	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PPARG—thyroid cancer	1.05e-05	0.000139	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.04e-05	0.000139	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—AKT1—thyroid cancer	1.04e-05	0.000139	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PRKAR1A—thyroid cancer	1.03e-05	0.000138	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—RXRA—thyroid cancer	1.02e-05	0.000136	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—RXRA—thyroid cancer	1.02e-05	0.000136	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRG1—thyroid cancer	1.02e-05	0.000135	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1e-05	0.000133	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—KRAS—thyroid cancer	9.93e-06	0.000132	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.93e-06	0.000132	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—SLC5A5—thyroid cancer	9.9e-06	0.000132	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTEN—thyroid cancer	9.89e-06	0.000132	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—RXRA—thyroid cancer	9.84e-06	0.000131	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—BRAF—thyroid cancer	9.83e-06	0.000131	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.82e-06	0.000131	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TERT—thyroid cancer	9.79e-06	0.00013	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—KRAS—thyroid cancer	9.69e-06	0.000129	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTEN—thyroid cancer	9.63e-06	0.000128	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.57e-06	0.000127	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—thyroid cancer	9.57e-06	0.000127	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—thyroid cancer	9.5e-06	0.000126	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CALCA—thyroid cancer	9.39e-06	0.000125	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.37e-06	0.000125	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HIF1A—thyroid cancer	9.36e-06	0.000125	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—RXRA—thyroid cancer	9.35e-06	0.000125	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.28e-06	0.000124	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRAS—thyroid cancer	9.15e-06	0.000122	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TERT—thyroid cancer	9.13e-06	0.000122	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.1e-06	0.000121	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.87e-06	0.000118	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NRAS—thyroid cancer	8.82e-06	0.000117	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HIF1A—thyroid cancer	8.73e-06	0.000116	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—thyroid cancer	8.61e-06	0.000115	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDK1—thyroid cancer	8.5e-06	0.000113	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TPR—thyroid cancer	8.5e-06	0.000113	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—HRAS—thyroid cancer	8.44e-06	0.000112	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	8.38e-06	0.000112	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PRKAR1A—thyroid cancer	8.36e-06	0.000111	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—RXRA—thyroid cancer	8.32e-06	0.000111	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTEN—thyroid cancer	8.28e-06	0.00011	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—NRAS—thyroid cancer	8.25e-06	0.00011	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—HRAS—thyroid cancer	8.24e-06	0.00011	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—thyroid cancer	8.23e-06	0.00011	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.09e-06	0.000108	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—AKT1—thyroid cancer	8.08e-06	0.000108	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PPARG—thyroid cancer	7.93e-06	0.000106	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PPARG—thyroid cancer	7.93e-06	0.000106	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC5A5—thyroid cancer	7.86e-06	0.000105	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—BRAF—thyroid cancer	7.75e-06	0.000103	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TPR—thyroid cancer	7.63e-06	0.000102	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KRAS—thyroid cancer	7.59e-06	0.000101	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.58e-06	0.000101	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	7.5e-06	9.99e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—AKT1—thyroid cancer	7.46e-06	9.93e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TPR—thyroid cancer	7.45e-06	9.91e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	7.44e-06	9.91e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	7.33e-06	9.75e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—AKT1—thyroid cancer	7.27e-06	9.68e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—BRAF—thyroid cancer	7.23e-06	9.62e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTEN—thyroid cancer	7.18e-06	9.56e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCND1—thyroid cancer	7.17e-06	9.55e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—KRAS—thyroid cancer	7.1e-06	9.45e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TPR—thyroid cancer	6.96e-06	9.26e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTEN—thyroid cancer	6.92e-06	9.22e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—thyroid cancer	6.91e-06	9.2e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	6.84e-06	9.11e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRG1—thyroid cancer	6.82e-06	9.08e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.8e-06	9.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—RXRA—thyroid cancer	6.61e-06	8.79e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—thyroid cancer	6.53e-06	8.69e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—thyroid cancer	6.45e-06	8.59e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—thyroid cancer	6.45e-06	8.58e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—thyroid cancer	6.45e-06	8.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.43e-06	8.55e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	6.38e-06	8.5e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC5A5—thyroid cancer	6.36e-06	8.47e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.29e-06	8.37e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—thyroid cancer	6.24e-06	8.31e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—thyroid cancer	6.24e-06	8.31e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—thyroid cancer	6.22e-06	8.27e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.2e-06	8.26e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—thyroid cancer	6.18e-06	8.22e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TERT—thyroid cancer	6.12e-06	8.15e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—thyroid cancer	6.04e-06	8.03e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.96e-06	7.94e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—thyroid cancer	5.91e-06	7.86e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—thyroid cancer	5.9e-06	7.86e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—thyroid cancer	5.87e-06	7.81e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HIF1A—thyroid cancer	5.86e-06	7.8e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—thyroid cancer	5.84e-06	7.77e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC5A5—thyroid cancer	5.71e-06	7.6e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—thyroid cancer	5.7e-06	7.59e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—thyroid cancer	5.66e-06	7.53e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC5A5—thyroid cancer	5.57e-06	7.42e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—thyroid cancer	5.55e-06	7.39e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—thyroid cancer	5.46e-06	7.27e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—thyroid cancer	5.44e-06	7.24e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—thyroid cancer	5.44e-06	7.24e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—thyroid cancer	5.43e-06	7.23e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.35e-06	7.12e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—RXRA—thyroid cancer	5.34e-06	7.12e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—thyroid cancer	5.33e-06	7.09e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—thyroid cancer	5.32e-06	7.08e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—thyroid cancer	5.32e-06	7.08e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—thyroid cancer	5.25e-06	7e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	5.21e-06	6.93e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.2e-06	6.92e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—thyroid cancer	5.15e-06	6.85e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—thyroid cancer	5.09e-06	6.78e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—thyroid cancer	5.09e-06	6.78e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—thyroid cancer	5.07e-06	6.75e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—thyroid cancer	5.07e-06	6.75e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—thyroid cancer	4.89e-06	6.51e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.88e-06	6.5e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—thyroid cancer	4.87e-06	6.49e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—thyroid cancer	4.85e-06	6.46e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—RXRA—thyroid cancer	4.8e-06	6.39e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—thyroid cancer	4.77e-06	6.35e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—thyroid cancer	4.74e-06	6.31e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—thyroid cancer	4.73e-06	6.29e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—RXRA—thyroid cancer	4.68e-06	6.23e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.67e-06	6.21e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—thyroid cancer	4.65e-06	6.19e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—thyroid cancer	4.54e-06	6.05e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—thyroid cancer	4.52e-06	6.02e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—thyroid cancer	4.42e-06	5.89e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—thyroid cancer	4.42e-06	5.89e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—thyroid cancer	4.38e-06	5.84e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—RXRA—thyroid cancer	4.37e-06	5.82e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—thyroid cancer	4.26e-06	5.68e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.26e-06	5.66e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—thyroid cancer	4.19e-06	5.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—thyroid cancer	4.17e-06	5.55e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—thyroid cancer	4.14e-06	5.51e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—thyroid cancer	4.13e-06	5.5e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—thyroid cancer	4.05e-06	5.39e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—thyroid cancer	3.99e-06	5.31e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—thyroid cancer	3.91e-06	5.2e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—thyroid cancer	3.9e-06	5.19e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—thyroid cancer	3.81e-06	5.08e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—thyroid cancer	3.73e-06	4.96e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—thyroid cancer	3.73e-06	4.96e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—thyroid cancer	3.6e-06	4.8e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—thyroid cancer	3.57e-06	4.75e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—thyroid cancer	3.42e-06	4.55e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—thyroid cancer	3.37e-06	4.49e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—thyroid cancer	3.32e-06	4.42e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—thyroid cancer	3.29e-06	4.38e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—thyroid cancer	3.15e-06	4.19e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—thyroid cancer	3.14e-06	4.18e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—thyroid cancer	3.14e-06	4.18e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—thyroid cancer	3.05e-06	4.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—thyroid cancer	3.03e-06	4.03e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—thyroid cancer	2.97e-06	3.95e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—thyroid cancer	2.96e-06	3.94e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—thyroid cancer	2.93e-06	3.91e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—thyroid cancer	2.86e-06	3.81e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—thyroid cancer	2.76e-06	3.68e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—thyroid cancer	2.73e-06	3.64e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—thyroid cancer	2.65e-06	3.53e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—thyroid cancer	2.62e-06	3.49e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—thyroid cancer	2.55e-06	3.39e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—thyroid cancer	2.55e-06	3.39e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—thyroid cancer	2.46e-06	3.27e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—thyroid cancer	2.38e-06	3.17e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—thyroid cancer	2.34e-06	3.11e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—thyroid cancer	2.33e-06	3.1e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—thyroid cancer	2.32e-06	3.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—thyroid cancer	2.23e-06	2.97e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.17e-06	2.89e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—thyroid cancer	2.08e-06	2.77e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—thyroid cancer	2.08e-06	2.77e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—thyroid cancer	2.03e-06	2.7e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—thyroid cancer	1.97e-06	2.62e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—thyroid cancer	1.89e-06	2.52e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—thyroid cancer	1.65e-06	2.2e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—thyroid cancer	1.33e-06	1.78e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—thyroid cancer	1.2e-06	1.59e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—thyroid cancer	1.17e-06	1.56e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—thyroid cancer	1.09e-06	1.45e-05	CbGpPWpGaD
